Phase 1 clinical trial provides valuable insights on safe and effective dosing of igc-ad1 for alzheimer's patients

Potomac, md,--(business wire)-- #igc--igc-ad1 phase 1 clinical trial provides valuable insights on safe and effective dosing of igc-ad1 for alzheimer's patients.

IGC Ratings Summary

IGC Quant Ranking